Voriconazole For Chronic Bronchopulmonary Aspergillosis
NCT00159822
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Aspergillosis
Interventions
DRUG:
Voriconazole
Sponsor
Pfizer